Diflucortolone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28F2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K253365DXI, chemically known as 6alpha,9-difluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione but generally known as diflucortolone, which bears US NIH Compound Identifier 17455. European Medicines Agency schedules Diflucortolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07128MIG. The term DIFLUCORTOLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules diflucortolone in its Anatomical Therapeutic Chemical (ATC) Classification. DIFLUCORTOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diflucortolone under HS 29372200 and SITC 54153. As of Q4 2014, DIFLUCORTOLONE remains the US FDA Preferred Term for this commodity. Diflucortolone bears US NLM identifiers UMLS ID C0012227 and NCI Concept Code C87231. SMILES: FC12C(C3C(C(C(C3)C)C(=O)CO)(CC1O)C)CC(F)C1=CC(=O)C=CC21C.